Hanmi Pharmaceutical and Seoul National University Join Hands to Establish a Global Pharmaceutical and Bio Talent Development Hub

Sejeong Oh, President of Seoul National University (left), and Sechang Kwon, CEO of Hanmi Pharmaceutical, are posing for a commemorative photo after signing a business agreement.

[Asia Economy Reporter Lee Gwan-joo] Hanmi Pharmaceutical announced on the 7th that it has signed a memorandum of understanding (MOU) with Seoul National University to collaborate on establishing a global bio workforce training hub.

This agreement was made to establish a cooperative system for project promotion following Korea's sole selection in February this year for the World Health Organization (WHO) Global Bio Workforce Training Hub project.

Through the agreement, both institutions promised to promote ▲ cooperation on educational programs related to the WHO Global Bio Workforce Training Hub selection ▲ collaboration to attract the Global Bio Workforce Campus project ▲ cooperation for sustainable development in the pharmaceutical bio R&D sector.

Seoul National University has formed a ‘Global Bio Campus Project Attraction Promotion Team’ for this project and plans to create a medical bio-health cluster for medical education, research, and industrialization at the Siheung Campus to build a pharmaceutical bio industry ecosystem network.

Hanmi Pharmaceutical plans to provide education on mRNA vaccine and biopharmaceutical process development, aseptic pharmaceutical manufacturing processes, and quality control related to cGMP, and to collaborate on joint research and development of bio innovative new drugs, AI, and medical-digital convergence new medical devices, while activating consultation and exchanges.

Seoul National University President Oh Se-jung said, “We expect to create opportunities for global pharmaceutical bio workforce training and sustainable growth in R&D by combining Hanmi Pharmaceutical’s know-how in global innovative new drug development with Seoul National University’s world-class bio and related education and research capabilities.”

Hanmi Pharmaceutical CEO Kwon Se-chang stated, “Through collaboration with Seoul National University, which has world-class education and research infrastructure, we will lay the foundation for nurturing excellent pharmaceutical bio talent and strive to enable Korea’s pharmaceutical bio industry to have differentiated competitiveness on the global stage.”

This content was produced with the assistance of AI translation services.